DexCom, Inc. (DXCM)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
87.42-2.32 (-2.59%)
As of 3:14 PM EDT. Market open.
People also watch:
PODDNUVAABMDELGXHTWR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open89.89
Prev Close89.74
Bid87.01 x 200
Ask87.10 x 200
Day's Range86.29 - 89.98
52wk Range47.92 - 96.38
1y Target EstN/A
Market Cap7.33B
P/E Ratio (ttm)-89.02
Beta0.59
Volume2,131,369
Avg Vol (3m)826,509
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • DexCom, Inc. breached its 50 day moving average in a Bearish Manner : DXCM-US : September 29, 2016
    Capital Cube7 hours ago

    DexCom, Inc. breached its 50 day moving average in a Bearish Manner : DXCM-US : September 29, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for DexCom, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • Reuters20 hours ago

    U.S. FDA approves Medtronic's 'artificial pancreas' for diabetes

    Medtronic Plc won U.S. approval on Wednesday for an "artificial pancreas" that is the first device to automatically deliver the right dose of insulin to patients with type 1 diabetes, freeing them from continually monitoring insulin levels throughout each day. The U.S. Food and Drug Administration, in its approval of the device, the MiniMed 670G, hailed it as a breakthrough. The device offers type 1 diabetics "greater freedom to live their lives without having to consistently and manually monitor baseline glucose levels and administer insulin," Dr. Jeffrey Shuren, director of the FDA's medical device division, said in a statement.

  • Business Wire2 days ago

    DexCom Schedules Third Quarter 2016 Earnings Release and Conference Call for November 1, 2016 at 4:30 p.m. Eastern Time

    DexCom, Inc. today announced that it plans to release its third quarter 2016 financial results after market close on Tuesday, November 1, 2016. Management will hold a conference call to review the company's third quarter 2016 performance starting at 4:30 p.m.